Financial Snapshot

Revenue
$260.8M
TTM
Gross Margin
82.58%
TTM
Net Earnings
$20.48M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
1322.63%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$681.4M
Q3 2024
Cash
Q3 2024
P/E
82.74
Nov 29, 2024 EST
Free Cash Flow
$22.69M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Revenue $232.3M $722.7M $439.4M $46.55M $35.22M $8.198M $327.0K $11.04M $4.050M $11.03M $11.25M $9.714M $21.61M $23.95M $40.32M $37.09M $14.09M $4.850M $14.66M $14.81M $830.0K $1.430M $2.360M $2.050M $450.0K $0.00
YoY Change -67.86% 64.45% 844.0% 32.18% 329.6% 2407.03% -97.04% 172.67% -63.28% -1.96% 15.82% -55.06% -9.75% -40.6% 8.71% 163.24% 190.52% -66.92% -1.01% 1684.34% -41.96% -39.41% 15.12% 355.56%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Revenue $232.3M $722.7M $439.4M $46.55M $35.22M $8.198M $327.0K $11.04M $4.050M $11.03M $11.25M $9.714M $21.61M $23.95M $40.32M $37.09M $14.09M $4.850M $14.66M $14.81M $830.0K $1.430M $2.360M $2.050M $450.0K $0.00
Cost Of Revenue $50.17M $262.2M $173.6M $13.91M $19.39M $21.80M
Gross Profit $182.1M $460.5M $265.9M $32.64M $15.83M -$13.60M
Gross Profit Margin 78.4% 63.73% 60.5% 70.12% 44.95% -165.89%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Selling, General & Admin $152.9M $131.4M $100.2M $79.26M $74.99M $64.77M $27.37M $37.26M $22.18M $17.76M $26.87M $28.16M $17.57M $16.88M $15.75M $15.46M $18.29M $14.84M $9.260M $8.540M $4.800M $4.120M $4.530M $3.450M $1.400M $1.120M
YoY Change 16.39% 31.2% 26.37% 5.69% 15.77% 136.67% -26.55% 67.98% 24.89% -33.9% -4.58% 60.27% 4.09% 7.17% 1.88% -15.47% 23.25% 60.26% 8.43% 77.92% 16.5% -9.05% 31.3% 146.43% 25.0% 38.27%
% of Gross Profit 83.98% 28.53% 37.67% 242.82% 473.7%
Research & Development $54.89M $46.60M $32.23M $28.61M $62.33M $74.95M $64.99M $84.49M $86.94M $84.58M $50.87M $49.15M $51.32M $53.68M $38.71M $44.77M $65.89M $50.12M $27.89M $23.13M $13.79M $15.97M $17.36M $8.270M $6.050M $5.980M
YoY Change 17.78% 44.59% 12.66% -54.1% -16.84% 15.33% -23.08% -2.82% 2.79% 66.27% 3.51% -4.24% -4.39% 38.67% -13.54% -32.05% 31.46% 79.71% 20.58% 67.73% -13.65% -8.01% 109.92% 36.69% 1.17% 103.4%
% of Gross Profit 30.14% 10.12% 12.12% 87.64% 393.75%
Depreciation & Amortization $4.342M $3.812M $4.296M $6.770M $18.16M $14.48M $4.430M $2.260M $1.370M $1.400M $1.330M $1.210M $1.600M $2.400M $2.840M $2.830M $2.480M $1.830M $760.0K $540.0K $580.0K $680.0K $480.0K $310.0K $220.0K $190.0K
YoY Change 13.9% -11.27% -36.54% -62.72% 25.41% 226.86% 96.02% 64.96% -2.14% 5.26% 9.92% -24.38% -33.33% -15.49% 0.35% 14.11% 35.52% 140.79% 40.74% -6.9% -14.71% 41.67% 54.84% 40.91% 15.79% 137.5%
% of Gross Profit 2.38% 0.83% 1.62% 20.74% 114.72%
Operating Expenses $207.8M $178.0M $132.4M $107.9M $137.3M $161.5M $96.33M $121.8M $109.1M $84.58M $50.87M $49.15M $51.32M $53.68M $55.43M $61.21M $85.19M $65.65M $37.15M $31.67M $18.59M $20.09M $21.89M $11.72M $7.450M $7.090M
YoY Change 16.75% 34.46% 22.73% -21.45% -14.98% 67.67% -20.88% 11.57% 29.02% 66.27% 3.51% -4.24% -4.39% -3.16% -9.44% -28.15% 29.76% 76.72% 17.3% 70.36% -7.47% -8.22% 86.77% 57.32% 5.08% 89.07%
Operating Profit -$37.03M $283.5M $134.5M -$68.37M -$134.8M -$175.1M -$96.01M -$110.7M -$105.1M -$91.31M -$66.49M -$67.60M -$47.58M -$47.59M
YoY Change -113.06% 110.82% -296.7% -49.3% -23.0% 82.4% -13.28% 5.36% 15.07% 37.33% -1.64% 42.08% -0.03%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Interest Expense $6.757M $6.732M $11.18M $19.06M $16.98M $9.338M $740.0K $760.0K $572.0K $35.00K $120.0K $2.351M $1.957M $1.654M $50.00K -$7.530M $2.450M $3.190M $1.940M $890.0K $410.0K $620.0K $1.120M $1.150M $440.0K $320.0K
YoY Change 0.37% -39.76% -41.37% 12.28% 81.81% 1161.89% -2.63% 32.87% 1534.29% -70.83% -94.9% 20.13% 18.32% 3208.0% -100.66% -407.35% -23.2% 64.43% 117.98% 117.07% -33.87% -44.64% -2.61% 161.36% 37.5% 33.33%
% of Operating Profit 2.37% 8.31%
Other Income/Expense, Net -$152.0K $111.0K $922.0K -$897.0K $731.0K -$70.00K -$486.0K -$2.492M $317.0K $433.0K -$348.0K -$293.0K $834.0K -$8.150M -$70.00K $110.0K
YoY Change -236.94% -87.96% -202.79% -222.71% -1144.29% -85.6% -80.5% -886.12% -26.79% -224.43% 18.77% -135.13% -110.23% 11542.86% -163.64%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Pretax Income -$4.367M $294.3M $77.52M -$75.24M -$152.6M -$154.6M -$95.90M -$114.5M -$107.5M -$91.12M -$67.00M -$70.79M -$49.99M -$56.38M -$15.13M -$26.54M -$68.65M -$61.80M -$20.56M -$15.97M -$17.35M -$18.04M -$18.41M -$8.520M -$6.560M -$6.780M
YoY Change -101.48% 279.64% -203.03% -50.69% -1.3% 61.22% -16.23% 6.55% 17.92% 35.99% -5.35% 41.61% -11.33% 272.63% -42.99% -61.34% 11.08% 200.58% 28.74% -7.95% -3.82% -2.01% 116.08% 29.88% -3.24% 93.16%
Income Tax $2.022M $1.143M $808.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.39% 1.04%
Net Earnings -$6.389M $293.2M $76.71M -$75.24M -$152.6M -$158.9M -$95.15M -$112.4M -$106.8M -$90.72M -$66.72M -$69.95M -$48.60M -$57.31M -$30.57M -$20.83M -$59.97M -$52.05M -$20.56M -$15.97M -$17.35M -$18.04M -$18.41M -$8.520M -$6.560M -$6.780M
YoY Change -102.18% 282.15% -201.96% -50.69% -3.96% 66.99% -15.38% 5.29% 17.72% 35.97% -4.62% 43.94% -15.2% 87.46% 46.76% -65.27% 15.22% 153.16% 28.74% -7.95% -3.82% -2.01% 116.08% 29.88% -3.24% 93.16%
Net Earnings / Revenue -2.75% 40.56% 17.46% -161.63% -433.29% -1938.27% -29099.08% -1018.24% -2636.89% -822.5% -593.01% -720.08% -224.84% -239.28% -75.82% -56.16% -425.62% -1073.2% -140.25% -107.83% -2090.36% -1261.54% -780.08% -415.61% -1457.78%
Basic Earnings Per Share -$0.05 $2.32 $0.62 -$0.75 -$2.16 -$2.55
Diluted Earnings Per Share -$0.05 $1.97 $0.57 -$0.78 -$2.16 -$2.55 -$1.809M -$2.920M -$3.248M -$3.451M -$3.399M -$4.103M -$3.885M -$6.947M -$7.567M -$5.234M -$15.11M -$16.11M -$7.938M -$7.533M -$7.321M -$7.612M -$7.768M -$3.595M -$2.768M -$2.861M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Cash & Short-Term Investments $742.3M $624.4M $546.0M $165.0M $151.1M $145.5M $191.9M $81.40M $196.1M $122.7M $189.4M $125.1M $114.0M $72.20M $36.70M $68.50M $88.20M $86.20M $75.10M $65.80M $29.10M $29.40M $11.80M $26.80M $8.500M $13.20M
YoY Change 18.88% 14.37% 230.88% 9.2% 3.85% -24.18% 135.75% -58.49% 59.82% -35.22% 51.4% 9.74% 57.89% 96.73% -46.42% -22.34% 2.32% 14.78% 14.13% 126.12% -1.02% 149.15% -55.97% 215.29% -35.61%
Cash & Equivalents $150.3M $202.0M $436.2M $32.10M $39.90M $49.30M $26.60M $24.30M $44.80M $49.50M $23.10M $7.600M $31.90M $22.50M $36.70M $28.10M $14.30M $14.20M $8.700M $16.60M $23.50M $5.200M $4.300M $26.80M $6.700M $6.300M
Short-Term Investments $592.0M $422.4M $109.8M $133.0M $111.2M $96.20M $165.3M $57.10M $151.3M $73.10M $166.3M $117.5M $82.00M $49.70M $0.00 $40.40M $74.00M $72.00M $66.40M $49.30M $5.600M $24.20M $7.400M $1.700M $7.000M
Other Short-Term Assets $19.00M $85.63M $233.4M $38.60M $7.400M $6.100M $5.000M $6.800M $2.400M $4.100M $1.400M $2.100M $1.100M $1.400M $600.0K $1.700M $6.400M $1.100M $1.700M $1.800M $1.400M $700.0K $400.0K $400.0K $300.0K
YoY Change -77.82% -63.32% 504.71% 421.62% 21.31% 22.0% -26.47% 183.33% -41.46% 192.86% -33.33% 90.91% -21.43% 133.33% -64.71% -73.44% 481.82% -35.29% -5.56% 28.57% 100.0% 75.0% 33.33%
Inventory $53.29M $59.45M $61.34M $63.70M $41.30M $19.00M $300.0K $0.00 $300.0K $0.00
Prepaid Expenses
Receivables $40.61M $145.1M $116.2M $22.70M $8.900M $3.700M $900.0K $1.300M $1.400M $700.0K $1.600M $1.000M $9.500M $1.000M $900.0K $6.400M $7.200M $2.200M $700.0K $3.100M $200.0K $0.00 $1.400M
Other Receivables $3.926M $2.385M $15.60M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $859.1M $917.0M $972.5M $290.0M $208.7M $174.4M $198.0M $89.60M $199.9M $127.4M $192.4M $128.2M $124.6M $74.50M $38.20M $76.50M $101.9M $89.70M $77.50M $70.80M $30.70M $30.10M $13.60M $26.80M $8.800M $13.60M
YoY Change -6.31% -5.71% 235.35% 38.96% 19.67% -11.92% 120.98% -55.18% 56.91% -33.78% 50.08% 2.89% 67.25% 95.03% -50.07% -24.93% 13.6% 15.74% 9.46% 130.62% 1.99% 121.32% -49.25% 204.55% -35.29%
Property, Plant & Equipment $61.58M $63.34M $60.98M $57.20M $62.30M $17.10M $16.60M $17.20M $13.80M $7.900M $8.700M $8.000M $6.200M $6.400M $8.000M $9.500M $7.300M $5.200M $2.200M $2.500M $800.0K $1.300M $1.500M $800.0K $700.0K
YoY Change -2.77% 3.86% 6.62% -8.19% 264.33% 3.01% -3.49% 24.64% 74.68% -9.2% 8.75% 29.03% -3.13% -20.0% -15.79% 30.14% 40.38% 136.36% -12.0% 212.5% -38.46% -13.33% 14.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $74.33M $3.518M $3.617M $3.800M $3.600M $5.600M $1.900M $900.0K $800.0K $700.0K $1.000M $1.100M $1.000M $700.0K $700.0K $0.00 $5.600M $1.300M $400.0K $400.0K $0.00 $100.0K $100.0K $2.800M $0.00 $0.00
YoY Change 2012.71% -2.74% -4.82% 5.56% -35.71% 194.74% 111.11% 12.5% 14.29% -30.0% -9.09% 10.0% 42.86% 0.0% -100.0% 330.77% 225.0% 0.0% -100.0% 0.0% -96.43%
Total Long-Term Assets $138.0M $68.87M $66.73M $63.30M $70.40M $36.50M $20.80M $20.10M $16.70M $10.90M $12.20M $11.60M $9.500M $9.700M $12.30M $14.10M $18.50M $13.20M $2.600M $2.800M $900.0K $1.400M $1.500M $2.800M $800.0K $700.0K
YoY Change 100.36% 3.21% 5.41% -10.09% 92.88% 75.48% 3.48% 20.36% 53.21% -10.66% 5.17% 22.11% -2.06% -21.14% -12.77% -23.78% 40.15% 407.69% -7.14% 211.11% -35.71% -6.67% -46.43% 250.0% 14.29%
Total Assets $997.1M $985.9M $1.039B $353.3M $279.1M $210.9M $218.8M $109.7M $216.6M $138.3M $204.6M $139.8M $134.1M $84.20M $50.50M $90.60M $120.4M $102.9M $80.10M $73.60M $31.60M $31.50M $15.10M $29.60M $9.600M $14.30M
YoY Change
Accounts Payable $5.245M $3.211M $2.600M $3.300M $9.300M $5.300M $4.500M $3.800M $3.400M $1.200M $1.900M $2.200M $2.000M $2.300M $1.700M $900.0K $4.400M $2.200M $1.000M $1.400M $1.400M $1.400M $400.0K $600.0K $1.000M
YoY Change 63.34% 23.5% -21.21% -64.52% 75.47% 17.78% 18.42% 11.76% 183.33% -36.84% -13.64% 10.0% -13.04% 35.29% 88.89% -79.55% 100.0% 120.0% -28.57% 0.0% 0.0% 250.0% -40.0%
Accrued Expenses $56.93M $146.9M $185.9M $25.20M $22.00M $25.80M $14.10M $16.20M $22.70M $13.30M $8.200M $10.10M $8.200M $10.20M $7.500M $6.800M $12.10M $10.70M $3.800M $4.400M $3.000M $2.100M $2.500M $300.0K $200.0K
YoY Change -61.24% -21.0% 637.73% 14.55% -14.73% 82.98% -12.96% -28.63% 70.68% 62.2% -18.81% 23.17% -19.61% 36.0% 10.29% -43.8% 13.08% 181.58% -13.64% 46.67% 42.86% -16.0% 50.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $12.80M $0.00 $2.600M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $0.00 $0.00 $200.0K $100.0K
YoY Change 100.0%
Total Short-Term Liabilities $62.20M $150.1M $556.4M $77.40M $53.00M $38.00M $18.60M $20.00M $28.80M $20.30M $16.20M $19.00M $27.20M $13.90M $14.50M $40.90M $19.90M $13.70M $5.500M $6.800M $4.400M $4.200M $4.100M $2.100M $2.200M $1.300M
YoY Change -58.56% -73.03% 618.87% 46.04% 39.47% 104.3% -7.0% -30.56% 41.87% 25.31% -14.74% -30.15% 95.68% -4.14% -64.55% 105.53% 45.26% 149.09% -19.12% 54.55% 4.76% 2.44% 95.24% -4.55% 69.23%
Long-Term Debt $222.7M $221.6M $220.5M $179.8M $178.6M $100.9M $0.00 $0.00 $0.00 $9.600M $0.00 $0.00 $0.00 $10.90M $9.300M $0.00 $0.00 $0.00 $0.00 $0.00 $83.60M $83.60M $51.30M $51.30M $24.20M $23.50M
YoY Change 0.51% 0.49% 22.63% 0.67% 77.01% -100.0% -100.0% 17.2% -100.0% 0.0% 62.96% 0.0% 111.98% 2.98%
Other Long-Term Liabilities $90.13M $33.19M $39.98M $37.40M $39.10M $8.900M $600.0K $400.0K $800.0K $8.000M $2.100M $5.900M $7.000M $7.300M $20.30M $33.60M $61.40M $10.10M $200.0K $7.000M $800.0K
YoY Change 171.6% -17.0% 6.9% -4.35% 339.33% 1383.33% 50.0% -50.0% -90.0% 280.95% -64.41% -15.71% -4.11% -64.04% -39.58% -45.28% 507.92% 4950.0% -97.14% 775.0%
Total Long-Term Liabilities $312.8M $254.8M $260.5M $217.2M $217.7M $109.8M $600.0K $400.0K $800.0K $17.60M $2.100M $5.900M $7.000M $18.20M $29.60M $33.60M $61.40M $10.10M $200.0K $7.000M $84.40M $83.60M $51.30M $51.30M $24.20M $23.50M
YoY Change 22.79% -2.19% 19.92% -0.23% 98.27% 18200.0% 50.0% -50.0% -95.45% 738.1% -64.41% -15.71% -61.54% -38.51% -11.9% -45.28% 507.92% 4950.0% -97.14% -91.71% 0.96% 62.96% 0.0% 111.98% 2.98%
Total Liabilities $375.0M $404.8M $816.9M $294.6M $270.8M $147.8M $19.20M $20.50M $29.60M $37.80M $18.30M $24.90M $34.20M $32.10M $44.10M $77.10M $89.70M $25.80M $5.700M $13.80M $103.5M $87.80M $55.30M $53.40M $26.40M $24.80M
YoY Change -7.36% -50.44% 177.28% 8.79% 83.22% 669.79% -6.34% -30.74% -21.69% 106.56% -26.51% -27.19% 6.54% -27.21% -42.8% -14.05% 247.67% 352.63% -58.7% -86.67% 17.88% 58.77% 3.56% 102.27% 6.45%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Basic Shares Outstanding 128.7M 126.4M 116.3M 100.8M 72.02M 62.36M
Diluted Shares Outstanding 128.7M 150.8M 133.0M 101.5M 72.02M 62.36M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $1.6944 Billion

About DYNAVAX TECHNOLOGIES CORP

Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. The company is headquartered in Emeryville, California and currently employs 408 full-time employees. The company went IPO on 2004-02-19. The firm's products include HEPLISAV-B hepatitis B vaccine and CpG 1018. Its HEPLISAV-B ((Recombinant)(Adjuvanted) is indicated for the prevention of infection caused by all known subtypes of the hepatitis B virus in adults 18 years of age and older. HEPLISAV-B is a two-dose hepatitis B vaccine for adults. The company also manufactures and sells CpG 1018 adjuvant, the adjuvant used in HEPLISAV-B. The company is also engaged in developing a multi-program clinical pipeline leveraging CpG 1018 adjuvant to develop improved vaccines for indications with unmet medical needs. Its Pipeline programs include vaccine candidates under development for shingles, tetanus, diphtheria, and pertussis (Tdap) and plague. Its Shingles vaccine program Z-1018, which is an investigational vaccine candidate being developed for the prevention of shingles in adults aged 50 and older.

Industry: Pharmaceutical Preparations Peers: Akero Therapeutics, Inc. Celldex Therapeutics, Inc. BridgeBio Pharma, Inc. VERACYTE, INC. CATALYST PHARMACEUTICALS, INC. Day One Biopharmaceuticals, Inc. LIGAND PHARMACEUTICALS INC Syndax Pharmaceuticals Inc SpringWorks Therapeutics, Inc.